Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01627093 · ClinicalTrials.gov registry record
Medical Data Collection of Patients With Head and Neck Cancer Treated With Proton Therapy
A clinical trial of Head and Neck Carcinoma, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- 450
- Enrollment target
- 1
- Study location
NCT01627093 is a study of Head and Neck Carcinoma that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 450 participants, above the 398-participant average among 30 other Head and Neck Carcinoma trials with a reported enrollment target (13% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01627093, a study of Head and Neck Carcinoma, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 450 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial collects medical information from patients with head and neck cancer that have received or are scheduled to receive proton therapy. Collecting and analyzing medical information from patients may provide information on the outcomes and treatment related side effects of proton therapy for head and neck cancer and help doctors improve therapy for future patients with head and neck cancer.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- OTHER Medical Chart Review
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 450 participants |
| Start Date | 2012-01-06 |
| Est. Completion | 2026-04-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01627093
The ClinicalTrials.gov registry entry for NCT01627093 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 398-participant average among 30 other Head and Neck Carcinoma trials with a reported enrollment target (13% higher). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Head and Neck Carcinoma appearing as the primary indexed condition, and to 2 interventions - of which Questionnaire Administration is the first listed.
NCT01627093 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT01627093 about?
NCT01627093 is a clinical study titled "Medical Data Collection of Patients With Head and Neck Cancer Treated With Proton Therapy". This trial collects medical information from patients with head and neck cancer that have received or are scheduled to receive proton therapy. Collecting and analyzing medical information from patients may provide information on the outcomes and treatment related side effects of proton therapy for h...
What is the current status of trial NCT01627093?
This trial is currently active not recruiting. The enrollment target is 450 participants. The study started on 2012-01-06. Estimated completion is 2026-04-30.
What conditions does trial NCT01627093 study?
This clinical trial studies the following conditions: Head and Neck Carcinoma.
What interventions are being tested in trial NCT01627093?
The interventions under investigation include: Questionnaire Administration (OTHER), Medical Chart Review (OTHER).
Who is sponsoring clinical trial NCT01627093?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01627093 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Head and Neck Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
RECRUITING · Phase 1
-
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
RECRUITING · Phase 1
-
A Financial Intervention (Financial Compass) to Identify and Address Financial Hardship Among Head and Neck Cancer Patients, Financial Compass Trial
RECRUITING · NA
-
Tongue-out Radiation Therapy (TORT) for the Mitigation of Radiotherapy-related Toxicities in Patients With Head and Neck Cancer
RECRUITING · NA
-
Cancer Genetic Testing in Ethnic Populations
RECRUITING · NA
-
Evaluation of Radiobiological Effects in Skin Toxicities Head and Neck Cancer Patients With PBS Proton Therapy
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.